Skip to main content

Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients.

Publication ,  Journal Article
Shaw, LJ; Hendel, R; Borges-Neto, S; Lauer, MS; Alazraki, N; Burnette, J; Krawczynska, E; Cerqueira, M; Maddahi, J; Myoview Multicenter Registry,
Published in: J Nucl Med
February 2003

UNLABELLED: Event rates associated with a normal or low-risk myocardial perfusion SPECT imaging study have been shown by numerous investigators to be associated with <1%/y of follow-up. Thus, the aim of this study was to evaluate the prognostic value of a normal (99m)Tc-tetrofosmin study in a geographically diverse registry of patients undergoing stress myocardial perfusion SPECT. A total of 4,728 consecutively tested patients who underwent stress (99m)Tc-tetrofosmin SPECT at 5 U.S. hospitals were included in this series. METHODS: Patients were monitored for the occurrence of major cardiac events and hospitalizations. Uniform methods of data collection and standardized epidemiologic methods for follow-up were used at all centers. We used a risk-adjusted, Cox proportional hazards model to assess time to cardiac death. RESULTS: Of the 4,728 patients, one third underwent adenosine stress SPECT and two thirds underwent treadmill exercise. The observed annualized survival rate for those patients with a normal (99m)Tc-tetrofosmin study was 0.6%. Similarly, excellent survival rates were noted for the male and female subsets of this population as well as for patients who could exercise and for those undergoing pharmacologic stress testing. Compared with prior published outcomes studies on stress (201)Tl or (99m)Tc-sestamibi SPECT, the overall survival rates were similar and ranged from 99.3% to 99.7%. CONCLUSION: Results from this large multicenter registry provide further supportive evidence that the excellent prognosis associated with a normal SPECT scan is independent of the radiopharmaceutical used.

Duke Scholars

Published In

J Nucl Med

ISSN

0161-5505

Publication Date

February 2003

Volume

44

Issue

2

Start / End Page

134 / 139

Location

United States

Related Subject Headings

  • United States
  • Tomography, Emission-Computed, Single-Photon
  • Survival Rate
  • Stress, Physiological
  • Risk Factors
  • Registries
  • Radiopharmaceuticals
  • Prognosis
  • Predictive Value of Tests
  • Organotechnetium Compounds
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shaw, L. J., Hendel, R., Borges-Neto, S., Lauer, M. S., Alazraki, N., Burnette, J., … Myoview Multicenter Registry, . (2003). Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. J Nucl Med, 44(2), 134–139.
Shaw, Leslee J., Robert Hendel, Salvador Borges-Neto, Michael S. Lauer, Naomi Alazraki, Joy Burnette, Elizabeth Krawczynska, Manuel Cerqueira, Jamshid Maddahi, and Jamshid Myoview Multicenter Registry. “Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients.J Nucl Med 44, no. 2 (February 2003): 134–39.
Shaw LJ, Hendel R, Borges-Neto S, Lauer MS, Alazraki N, Burnette J, et al. Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. J Nucl Med. 2003 Feb;44(2):134–9.
Shaw LJ, Hendel R, Borges-Neto S, Lauer MS, Alazraki N, Burnette J, Krawczynska E, Cerqueira M, Maddahi J, Myoview Multicenter Registry. Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. J Nucl Med. 2003 Feb;44(2):134–139.

Published In

J Nucl Med

ISSN

0161-5505

Publication Date

February 2003

Volume

44

Issue

2

Start / End Page

134 / 139

Location

United States

Related Subject Headings

  • United States
  • Tomography, Emission-Computed, Single-Photon
  • Survival Rate
  • Stress, Physiological
  • Risk Factors
  • Registries
  • Radiopharmaceuticals
  • Prognosis
  • Predictive Value of Tests
  • Organotechnetium Compounds